Pasithea Therapeutics Corp.
KTTA
DELAYED 1 MONTH

7 insider filings · Latest: May 1, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 5 8:42 PMTiago MarquesDirector, Chief Executive Officer
Grant/Award
1,756,069$0.8411,756,069(D)

View →

May 1, 2026May 5 8:42 PMSTEINMAN LAWRENCEDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:41 PMSimon DumesnilDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:41 PMDaniel H SchneidermanChief Financial Officer
Grant/Award
1,129,323$0.8411,129,323(D)

View →

May 1, 2026May 5 8:41 PMKartik KrishnanChief Medical Officer
Grant/Award
1,129,323$0.8411,129,323(D)

View →

May 1, 2026May 5 8:41 PMEmer LeahyDirector
Grant/Award
152,783$0.841152,783(D)

View →

May 1, 2026May 5 8:40 PMAlfred J NovakDirector
Grant/Award
152,783$0.841152,783(D)

View →